In this presentation from Lymphoma & Myeloma 2016, Dr. Kenneth C. Anderson discusses new paradigms and therapies in the treatment of relapsed/refractory myeloma, with an emphasis on small molecules and monoclonal antibodies.
Earn CME credit for a related activity at the following location:
http://elc.imedex.com/ELC/Specialty-Search.aspx?search=7225
© 2016 Imedex, LLC.